focus -WSS

focus

author：Wikipedia 2025-10-02 17:27:45 - browse：46122

LIONEL BONAVENTURE/AFP via Getty Images

On Tuesday, Duke Health and Microsoft announced a five-year partnership that will support artificial intelligence applications in medicine, with a focus on building out infrastructure such as cloud-based data platforms.

Duke Health and Microsoft are both members of the Coalition for Health AI, a group of companies, hospitals, and federal agencies that formed late last year to develop guidelines for the responsible use of AI in medicine. “We have all these operational things we want to do in the health system, and we also have an academic interest in trustworthy AI,” said Jeffrey Ferranti, senior vice president and chief digital officer of Duke Health.

So Duke and Microsoft will collaborate within the newly-established Duke Health AI Innovation Lab and Center of Excellence, where researchers can develop new AI tools “while paying attention to some of the things that could go wrong,” said Ferranti. “Because there are a lot of things that can go wrong as we introduce new technology.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Precocious puberty in girls comes with mental health risks

WSS

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Meta's Zuckerberg and Chan on track to put $50 billion into science

Medtronic CEO on promising devices for diabetes, hypertension

Biden's order seeks to regulate AI risk without stifling innovation

Cassava reveals details — and problems — with Alzheimer's study

Why Sanofi got shellacked over its spinoff

focus

focus

hotspot

Medical records are filled with copy

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

United colonoscopy coverage change 'may cost lives,' doctors say

Testing for cancer recurrence creates a new limbo for patients

Activists slam private health insurers over coverage restrictions

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

23andMe had bad news about my health. I wish a person had delivered it

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

ChatGPT in medicine: STAT answers readers' burning questions

First Opinion Podcast: How to protect health care in times of war

leisure time

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

First medicine developed to treat MASH expected to be approved soon

CDC recommends rationing of RSV shot due to shortages

Sen. Paul opposes bill to ban Chinese biotechs

What it’s like to watch children die of measles

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

focus

Wikipedia

entertainment

hotspot